A customer of Cost Plus Drugs received an email from the company in October stating that “due to skyrocketing demand,” shipping times have been delayed. Marley Drug, a competitor, said its company has not experienced delays and presented itself as an alternative for Americans.
Many startups are giving patients options to receive care that cuts out insurers. This includes online pharmacies, direct primary care platforms and lending companies. These startups are creating change among payers, some experts say.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.